VB
Vikas Bhardwaj
Medical Technologist, AIIMS New Delhi
Updated: Apr 17, 2026
**Core Concept**
Acromegaly is a disorder caused by an overproduction of growth hormone (GH) due to an abnormality of the pituitary gland, often resulting in the growth of a pituitary tumor. The goal of pharmacological therapy in this condition is to reduce GH production and alleviate symptoms.
**Why the Correct Answer is Right**
Somatostatin analogs, such as octreotide, are effective in treating acromegaly by reducing GH production. They act by binding to somatostatin receptors on the surface of pituitary tumor cells, thereby inhibiting the release of GH. This is particularly useful in cases where surgical treatment has been only partially effective in controlling the disease.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because dopamine agonists, such as bromocriptine, are primarily used to treat prolactinomas, a type of pituitary tumor that secretes excess prolactin, not acromegaly.
* **Option B:** This option is incorrect because cabergoline is a dopamine agonist that is primarily used to treat hyperprolactinemia, not acromegaly. While it may have some effect on GH levels, it is not the first-line treatment for this condition.
* **Option D:** This option is incorrect because pegvisomant is a GH receptor antagonist that is used to treat acromegaly, but it is typically used as an adjunct therapy to somatostatin analogs, not as a first-line treatment.
**Clinical Pearl / High-Yield Fact**
Somatostatin analogs, such as octreotide, can cause gastrointestinal side effects, including diarrhea and abdominal pain. These side effects are often dose-limiting and may require dose adjustments or the use of other medications to manage symptoms.
**Correct Answer:** C. Octreotide.